Journal issues > Issue Special, Februari 2024 > Continued axillary surgery de-escalation in patients with early-stage breast cancer

Continued axillary surgery de-escalation in patients with early-stage breast cancer

By: T. Feys MBA, MSc

The role of axillary surgery for patients with early breast cancer has evolved significantly over the past few decades. A number of studies presented at SABCS again showed that de-escalation of axillary surgery has little to no effect on oncologic outcomes and can reduce lymphedema and other unwelcome outcomes for low-risk breast cancer patients.

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top